Clinical Trial Update: RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis [Phase 2]

View source ↗

Summary

This document provides a clinical trial update on RVU120 in patients with intermediate- or high-risk primary or secondary myelofibrosis, currently in Phase 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• RVU120 (SEL120)

Snippet

Sponsor: Ryvu Therapeutics SA | Conditions: Myelofibrosis | Phase 2 | Status: RECRUITING